Abstract
During investigating the expression of Gr-1 antigen on various subsets of mouse spleen cells, we found that Gr-1 was expressed on memory-type CD8 +CD44highCD62Lhigh T cells in addition to granulocytes. Intraperitoneal administration of anti-Gr-1 mAb caused almost complete elimination of Ly-6C+ memory-type CD8+ T cells as well as Ly-6G+ granulocytes. Anti-Gr-1 mAb-treated mouse spleen cells exhibited greatly reduced IFN-γ production in response to anti-CD3 mAb both in vitro and in vivo. This reduced cytokine production appeared to be derived from elimination of IFN-γ-producing Gr-1+CD8 + T cells. Indeed, CD8+ T cells with IFN-γ- producing activity and cytotoxicity were generated from isolated Gr-1 +CD8+ cells but not from Gr-1-CD8+ T cells. We also demonstrated that therapeutic effect of MBL-2 tumor-immunized spleen cells was greatly reduced by anti-Gr-1 mAb-treatment. Thus, we initially demonstrated that anti-Gr-1 mAb might become a good tool to investigate a precise role for memory-type CD8+ T cells in vivo.
Original language | English (US) |
---|---|
Pages (from-to) | 98-105 |
Number of pages | 8 |
Journal | Cellular Immunology |
Volume | 224 |
Issue number | 2 |
DOIs | |
State | Published - Aug 2003 |
Keywords
- Antitumor activity
- CD8 T cell
- Gr-1
- IFN-γ
- Memory-type
ASJC Scopus subject areas
- Immunology